| 2023-03-31 |
详情>>
股本变动：
变动后总股本626.77万股
|
| 2023-03-31 |
详情>>
业绩披露：
2022年年报每股收益-3.87美元,归母净利润-2269万美元,同比去年增长44.47%
|
| 2022-11-14 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-3.15美元,归母净利润-1843.1万美元,同比去年增长-15.1%
|
| 2022-11-02 |
详情>>
拆分方案：
每5.0000合并分成1.0000股
|
| 2022-08-22 |
详情>>
业绩披露：
2022年中报每股收益-0.51美元,归母净利润-1496.8万美元,同比去年增长-29.57%
|
| 2022-08-15 |
财报披露：
美东时间 2022-08-15 盘后发布财报
|
| 2022-06-14 |
股东大会：
将于2022-07-14召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to the Company’s Board of Directors to hold office for the following year until their successors are elected;
2.To approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement;
3.To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers;
4.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2022;
5.To approve an amendment to our certificate of incorporation, as amended, to authorize our board of directors in its discretion to effect a reverse stock split (the “Reverse Split”) of our issued and outstanding shares of common stock, at a specific ratio, ranging from one-for-five (1:5) to one-for-fifteen (1:15), at any time prior to the one-year anniversary date of the Annual Meeting, with the timing and exact ratio to be determined by the board of directors if effected;
6.To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 20% or more of the Company’s issued and outstanding common stock from time to time at the Company’s discretion pursuant to the Company’s purchase agreement with Lincoln Park Capital Fund, LLC, dated March 28, 2022;
7.To consider any other matters that may properly come before the Annual Meeting.
|
| 2022-05-16 |
详情>>
业绩披露：
2022年一季报每股收益-0.32美元,归母净利润-916.3万美元,同比去年增长-24.4%
|
| 2022-03-30 |
详情>>
业绩披露：
2021年年报每股收益-1.81美元,归母净利润-4085.9万美元,同比去年增长-410.67%
|
| 2021-11-12 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-0.78美元,归母净利润-1601.3万美元,同比去年增长-278.38%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-16 |
详情>>
业绩披露：
2021年中报每股收益-0.72美元,归母净利润-1155.2万美元,同比去年增长-249.43%
|
| 2021-05-17 |
详情>>
业绩披露：
2021年一季报每股收益-2.31美元,归母净利润-736.6万美元,同比去年增长-273.34%
|
| 2021-03-31 |
详情>>
业绩披露：
2020年年报每股收益-3.16美元,归母净利润-800.1万美元,同比去年增长-19.28%
|
| 2021-02-16 |
股东大会：
将于2021-03-24召开股东大会
会议内容 ▼▲
- 1.To consider and vote upon a proposal to approve the issuance of shares of CGI Common Stock, warrants and options pursuant to the Agreement and Plan of Merger and Reorganization, dated as of August 21, 2020, by and among CGI, Merger Sub, and StemoniX, a copy of which is attached as Annex A-1 to this proxy statement/prospectus/information statement, as amended by the Amendment No. 1 to Agreement and Plan of Merger and Reorganization dated February 8, 2021, a copy of which is attached as Annex A-2 to this proxy statement/prospectus/information statement (the “Stock Issuance Proposal”);
2.To consider and vote upon an amendment to the certificate of incorporation of CGI to effect a reverse stock split of both the issued and outstanding and authorized CGI Common Stock, at a ratio in the range from 1-for-2 to 1-for-10, with such ratio to be determined in the discretion of CGI’s board of directors and with such reverse stock split to be effected at such time and date as determined by CGI’s board of directors in its sole discretion (the “Reverse Split”), the form of which is attached as Annex B to this proxy statement/prospectus/information statement (the “Reverse Stock Split Proposal”);
3.To consider and vote upon a proposal to approve the Cancer Genetics, Inc. 2021 Equity Incentive Plan, the form of which is attached as Annex C to this proxy statement/prospectus/information statement, and to authorize for issuance 4,500,000 shares of CGI Common Stock thereunder (the “Plan Proposal”);
4.To approve, on an advisory basis, the compensation that may be paid or become payable to CGI’s named executive officers in connection with the merger, as disclosed in this proxy statement/prospectus/information statement (the “Executive Compensation Proposal”);
5.To consider and vote upon an adjournment of the CGI special meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the CGI special meeting to approve the proposals submitted at the CGI special meeting (the “Adjournment Proposal”).
|
| 2021-01-29 |
复牌提示：
2021-01-28 15:45:17 停牌，复牌日期 2021-01-28 16:00:00
|
| 2020-11-12 |
详情>>
业绩披露：
2020年三季报(累计)每股收益-1.93美元,归母净利润-423.2万美元,同比去年增长34.03%
|
| 2019-10-25 |
详情>>
拆分方案：
每30.0000合并分成1.0000股
|
| 2019-04-29 |
股东大会：
将于2019-05-31召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the next Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified;
2.To approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement;
3.To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers;
4.To approve and ratify, for purposes of Nasdaq Rule 5635(d), the potential issuance of shares of common stock equal to 20% or more of our pre-transaction outstanding common stock upon conversion of the outstanding balance (including interest thereon) of the Credit Agreement, dated September 18, 2018, between NovellusDx Ltd. and the Company;
5.To approve an amendment to the Company’s certificate of incorporation, the form of which is attached as Annex A to this proxy statement, to effect a reverse stock split of common stock, at a ratio in the range from 5-for-1 to 30-for-1, with such specific ratio to be determined by the Company’s board of directors following the Annual Meeting;
6.To consider any other matters that may properly come before the Annual Meeting.
|
| 2019-01-14 |
详情>>
内部人交易：
ROBERTS JOHN A等共交易3笔
|
| 2017-04-21 |
股东大会：
将于2017-06-07召开股东大会
会议内容 ▼▲
- 1.To elect eight directors to serve until the next Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified;
2.To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the year ending December 31, 2017;
3.To consider any other matters that may properly come before the Annual Meeting.
|
| 2016-09-12 |
股东大会：
将于2016-10-11召开股东大会
会议内容 ▼▲
- 1. To elect eight directors to serve until the next Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified;
2. To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the year ending December 31, 2016;
3. To approve an increase in the number of shares available for issuance under the Amended and Restated 2011 Equity Incentive Plan by 500,000 shares;
4. To consider any other matters that may properly come before the Annual Meeting.
|
| 2015-04-15 |
股东大会：
将于2015-05-14召开股东大会
会议内容 ▼▲
- 1. To elect eight directors to serve until the next Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified;
2. To ratify the appointment of McGladrey LLP as our independent registered public accounting firm for the year ending December 31, 2015;
3. To approve an increase in the amount of shares available for issuance under the Amended and Restated 2011 Equity Incentive Plan by 650,000 shares;
4. To consider any other matters that may properly come before the Annual Meeting.
|